Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

RDO nets $56.4mm for Pharmacyclics

Executive Summary

Pharmacyclics Inc. (developing treatments for cancer and immune-mediated diseases) netted $56.4mm through the registered direct offering of 6.45mm common shares at $8.85 each (a 10% premium). The company's CEO bought 678k of the stock.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies

UsernamePublicRestriction

Register